TariffloLookup
Tarifflo homeLoginSign up free
Tarifflo/Companies/NORTHSTAR DISTRIBUTION CENTER 8912Snapshot · Q1 2026 (Jan – Mar)
Importer profile· US

NORTHSTAR DISTRIBUTION CENTER 8912

NORTHSTAR DISTRIBUTION CENTER 8912 supplier risk profile Q1 2026—27 suppliers, India-focused pharma sourcing, B-grade risk score.

Supplier score
72B
/ 100
Q1 shipments
165
Tier-1 suppliers
27
Source countries
4
Top country
India · 87%
Q1 2026 overview

What this importer's trade footprint looks like

NORTHSTAR DISTRIBUTION CENTER 8912 processed 165 shipments in Q1 2026 across 27 suppliers in 4 countries. India dominated the sourcing footprint with 144 shipments (87.3% of total volume), driven primarily by pharmaceutical manufacturers including Aurobindo Pharma (33 shipments), Macleods Pharmaceuticals Godown (17), and Zydus Lifesciences (15). The import activity centers on HS Chapter 30 (pharmaceutical products), with secondary exposure to Chapter 30 subheadings 300490 and 300420. Extended supplier visibility extends to 26 tier-2 and 43 tier-3 entities in the sourcing network.

Compliance

Sanctions watchlist & forced-labor exposure

Sanctions screen
1 flagged supplier
  • UMEDICA LABORATORIES
    Matches Medicus Laboratories, LLC · 62% similarity
    SAM Exclusions
UFLPA forced-labor proximity
No suppliers in proximity to documented sites

Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.

One name on the importer's shipment records registered a match against sanctions watchlists. No suppliers in the active supply chain show documented exposure under the Uyghur Forced Labor Prevention Act (UFLPA) or similar forced-labor proximity indicators.

Risk score

Composite breakdown · 72 / 100

Activity
84
Diversification
19
Stability
54
Recency
100
Forwarder-clean
92
HS consistency
60
Forced-labor proximity
100
Sanctions clean
96
Tier 1

Top suppliers

27 distinct tier-1 suppliers in Q1 2026

AUROBINDO PHARMAIndia33
MACLEODS PHARMACEUTICALS GODOWNIndia17
ZYDUS LIFESCIENCESIndia15
AVET LIFESCIENCES PRIVATEIndia12
INDOCO REMEDIESIndia11
DR REDDY S LABORATORIESIndia11
ANNORA PHARMA PRIVATEIndia10
HETERO LABSIndia9
Geography

Country mix

Share of Q1 2026 inbound shipments by source country

India
87%
144
Sri Lanka
4%
7
China
3%
5
Malaysia
1%
2
Cargo

Top HS codes

HS 300490
2 shipments
1% of mix
HS 300420
1 shipments
1% of mix
Locked

Tier 2 / Tier 3 supplier graph

26 tier-2 + 43 tier-3 nodes mapped - sign up to see them.

Tier-2 supplier #1 · CN
Tier-3 supplier #2 · CN
Tier-2 supplier #3 · CN
Tier-3 supplier #4 · CN
Tier-2 supplier #5 · CN
Tier-3 supplier #6 · CN
Tier-2 supplier #7 · CN
Tier-3 supplier #8 · CN
Unlock the full graph

See live data, not just the Q1 2026 (Jan – Mar) snapshot.

Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.

Create free account
Methodology. Snapshot built from US Customs AMS import and export bill-of-lading records arrived between Q1 2026 (Jan – Mar). Supplier risk score is a composite of activity, diversification, stability, recency, forwarder-cleanness, HS consistency, sanctions screen, and forced-labor proximity. Sanctions screen runs trigram similarity against the OpenSanctions FTM corpus (4.2M+ records, 32,982 sanctioned entities, 91,894 names + aliases). Forced-labor proximity is a haversine distance from each CN supplier's resolved coordinate to the nearest of 380 documented facilities in the ASPI Xinjiang Data Project. This page shows the Q1 2026 (Jan – Mar) snapshot only - sign up for live updates.
Tarifflo Logo

AI-driven trade automation platform
for modern companies.

Platform

Classifications
ABI Filing
API Access

Company

Contact

Resources

Help Center

Legal

Privacy
Terms

© 2026 Tarifflo, Inc. All rights reserved.